Group 1 - The core viewpoint of the news highlights the performance of the medical innovation sector, with the China Securities Medical and Medical Device Innovation Index (931484) rising by 0.51% and notable increases in constituent stocks such as Ganli Pharmaceutical (3.05%) and Zhejiang Pharmaceutical (2.29%) [1] - The Medical Innovation ETF (516820) has seen a net inflow of funds over the past five days, with a peak single-day net inflow of 40.537 million yuan, totaling 62.4623 million yuan, averaging a daily net inflow of 12.4925 million yuan [1] - Baichuan Intelligent has launched the Baichuan-M3 Plus evidence-enhanced medical model, achieving a hallucination rate of 2.6%, the lowest globally, and introduced the "Evidence Anchoring" technology to provide citation sources for medical conclusions [1] Group 2 - Everbright Securities emphasizes that the AI+ healthcare sector should focus on several core areas: AI drug development, AI medical imaging, AI chronic disease management, and AI surgical robots, highlighting the strong willingness of pharmaceutical companies to invest in AI drug development due to its potential to significantly shorten drug development cycles [2] - The China Securities Medical and Medical Device Innovation Index selects 30 publicly listed companies with good profitability and growth potential from the pharmaceutical and healthcare sector, reflecting the overall performance of profitable and growth-oriented companies [2] - As of December 31, 2025, the top ten weighted stocks in the index include WuXi AppTec, Hengrui Medicine, Mindray Medical, and others, accounting for 63.75% of the total index weight [2]

（文章来源：证券日报） 证券日报网讯 1月22日，健帆生物发布公告称，公司于2025年12月11日召开2025年第一次临时股东大 会，审议通过了《关于变更经营范围、修订的议案》，同意根据有关法律、法规、规范性文件的规定， 结合公司经营范围调整的情况，对《公司章程》进行修订，并授权公司经营管理层全权办理上述变更涉 及的工商登记、备案手续。公司已于近日完成工商变更登记和备案手续的办理。 ...

证券代码：300529 证券简称：健帆生物 公告编号：2026-002 债券代码：123117 债券简称：健帆转债 健帆生物科技集团股份有限公司 关于完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 健帆生物科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 11 日 召开 2025 年第一次临时股东大会，审议通过了《关于变更经营范围、修订＜公 司章程＞的议案》，同意根据现行《中华人民共和国公司法》《上市公司章程指引》 《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等有关法律、法规、规范性文件的规定， 结合公司经营范围调整的情况，对《公司章程》进行修订，并授权公司经营管理 层全权办理上述变更涉及的工商登记、备案手续。 公司已于近日完成工商变更登记和备案手续的办理，本次工商变更登记完成 后的具体相关信息如下： 一、基本情况 1、名称：健帆生物科技集团股份有限公司 2、统一社会信用代码：914404006175105107 3、类型：其他股份有限公司（上市） 6 ...

Group 1 - The core point of the news is the recognition of Dong Fan, Chairman and President of Jianfan Group, as the "National Excellent Private Entrepreneur Caring for Employees," making Jianfan Group the only enterprise in Guangdong Province to receive this honor [1][3][5] - The award aims to acknowledge private entrepreneurs who have made significant contributions to promoting high-quality employment, fulfilling social responsibilities, and creating harmonious labor relations [5] - Jianfan Group emphasizes a people-oriented approach, focusing on employee care and shared development outcomes, which has led to significant economic and social benefits, including the global promotion of innovative blood adsorption technology [6][8] Group 2 - Under Dong Fan's leadership, Jianfan Group has implemented comprehensive labor contracts and social insurance coverage, ensuring steady wage growth for employees [8] - The company has established a holistic support system for employees, including facilities like "Union Love Mom's Room" and "Health Room," to provide a warm and healthy working environment [8] - Jianfan Group has received multiple honors for its efforts in building harmonious labor relations, including "National Model Worker Home" and "National Harmonious Labor Relations Innovation Demonstration Enterprise" [8]

Group 1 - The "National Employment and Social Security Advanced Private Enterprises and Caring for Employees Achieving Win-Win Award Ceremony" was held, recognizing 6 private enterprises and 2 individuals from Guangdong Province for their contributions to employment and social security [1] - Five private enterprises from Guangdong received the title of "National Employment and Social Security Advanced Private Enterprises," including Vipshop (China) Co., Ltd., Huizhou EVE Energy Co., Ltd., Guangdong JY Technology Co., Ltd., Guangdong Micro容 Electronic Technology Co., Ltd., and Jin Sanjiang (Zhaoqing) Silicon Materials Co., Ltd. [1] - Vipshop (China) Co., Ltd. has recruited over 1,000 college graduates through its "Youth with Vipshop" campus recruitment project and has employed 209 disabled employees [1] - Huizhou EVE Energy Co., Ltd. has become a globally competitive lithium battery platform with over 28,000 employees worldwide, including 7,960 employees in the parent company by 2024 [1] - Guangdong JY Technology Co., Ltd. has established three production bases in Meizhou, creating numerous quality job opportunities for local villagers and industrial workers [1] Group 2 - Guangdong Micro容 Electronic Technology Co., Ltd. has provided over 2,800 job opportunities in the past five years through innovative models such as "online live streaming job placement" and "town and village officials leading job placements," achieving a 100% signing rate for labor contracts and social insurance participation [2] - Jin Sanjiang (Zhaoqing) Silicon Materials Co., Ltd. focuses on product innovation and process technology optimization, forming a research and development team composed of PhDs, Masters, and technical experts [2] Group 3 - Guangdong Haida Group Co., Ltd. was awarded the "National Double Love and Double Evaluation Advanced Enterprise Union," creating five service platforms for employees and aiming for high-quality development [4] - Jianfan Biotechnology Group Co., Ltd.'s chairman, Dong Fan, received the "National Caring for Employees Excellent Private Entrepreneur" award, emphasizing the importance of employees as the most valuable asset for enterprise development [4] - Yejie, an engineer at Keshun Waterproof Technology Co., Ltd., was recognized as a "National Employee Who Loves the Enterprise," having worked in the construction waterproofing field for 21 years and receiving multiple honors [4]

证券代码：300529 证券简称：健帆生物 公告编号：2026-001 债券代码：123117 债券简称：健帆转债 健帆生物科技集团股份有限公司 关于 2025 年第四季度健帆转债转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 15 号——可转换公司债券》等有关规定，健帆生物科技集团股份 有限公司（以下简称"公司"）现将 2025 年第四季度可转换公司债券（以下简 称"健帆转债"）转股及公司股本变化情况公告如下： 一、可转换公司债券发行上市情况 （一）可转换公司债券发行情况 经中国证券监督管理委员会"证监许可[2020]3617 号"文同意注册，健帆生 物科技集团股份有限公司于 2021 年 6 月 23 日向不特定对象发行了 1,000.00 万张 可转换公司债券，每张面值 100 元，发行总额人民币 100,000.00 万元。本次向不 特定对象发行的可转债向公司在股权登记日收市后登记在册的原股东优先配售， 原股东优先配售后余额部分（含原股东放弃优 ...

格隆汇12月31日丨健帆生物(300529.SZ)公布，鉴于当前公司经营所面临的内外部环境与公司制定奋斗 者一号员工持股计划之时相比发生了较大变化，达成公司层面业绩考核指标已无较大可能性，结合公司 实际情况并考虑到参与员工的资金占用成本，若继续实施员工持股计划将难以达到预期激励目的和效 果。综合员工持股计划对象的意愿、近期市场环境因素以及公司未来发展战略规划，为更好地维护公 司、股东和员工的利益，经慎重考虑，公司决定提前终止奋斗者一号员工持股计划。 责任编辑：钟离 财经频道更多独家策划、专家专栏，免费查阅>> ...

格隆汇12月31日丨健帆生物(300529.SZ)公布，鉴于当前公司经营所面临的内外部环境与公司制定奋斗 者二号员工持股计划之时相比发生了较大变化，达成公司层面业绩考核指标已无较大可能性，结合公司 实际情况并考虑到参与员工的资金占用成本，若继续实施员工持股计划将难以达到预期激励目的和效 果。综合员工持股计划对象的意愿、近期市场环境因素以及公司未来发展战略规划，为更好地维护公 司、股东和员工的利益，经慎重考虑，公司决定提前终止奋斗者二号员工持股计划。 ...

格隆汇12月31日丨健帆生物(300529.SZ)公布，鉴于当前公司经营所面临的内外部环境与公司制定奋斗 者二号员工持股计划之时相比发生了较大变化，达成公司层面业绩考核指标已无较大可能性，结合公司 实际情况并考虑到参与员工的资金占用成本，若继续实施员工持股计划将难以达到预期激励目的和效 果。综合员工持股计划对象的意愿、近期市场环境因素以及公司未来发展战略规划，为更好地维护公 司、股东和员工的利益，经慎重考虑，公司决定提前终止奋斗者二号员工持股计划。 ...

证券代码：300529 证券简称：健帆生物 公告编号：2025-100 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 债券代码：123117 债券简称：健帆转债 健帆生物科技集团股份有限公司 关于向银行申请综合授信额度的公告 律法规及《公司章程》等有关规定，本议案无需提交公司股东大会审议。 四、备查文件 健帆生物科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 31 日召开了第五届董事会第三十八次会议，审议通过了《关于向银行申请综合授信 额度的议案》。根据公司经营发展需要及资金安排，公司拟向银行申请不超过人 民币 15 亿元（含本数，最终以银行实际审批的授信额度为准）的综合授信额度， 该综合授信额度的有效期限为自董事会审议通过之日起 12 个月内有效。 一、公司本次向银行申请授信额度的情况 根据公司经营发展需要及资金安排，董事会同意公司及其子公司向银行申请 总额不超过人民币 15 亿元的综合授信额度，授信期限为 1 年。授信的品种包括 但不限于银行承兑汇票、信用证、保函、备用信用证、贸易融资、借款等。具体 银行名称及拟申请额度情况以公司与相 ...